DiPersio receives innovation award | Washington University School of Medicine in St. Louis
Oncologist recognized for developing new therapies for blood cancers
Oncologist recognized for developing new therapies for blood cancers
During a Case-Based Roundtable® event, Sumanta Kumar Pal, MD, discussed regimens for recurrent metastatic clear cell renal cell carcinoma including lenvatinib plus everolimus, belzutifan, and…
An abstract is unavailable.
Nearly half of U.S. adults have faced medical debt. It can follow patients and their families for years, robbing them of life’s most meaningful opportunities…
It’s time for the “4th Annual National Black Family Cancer Awareness Week, Engaging the Generations” Conversation on Cancer public panel discussion. The June…
Miles for Moffitt gives patients like Kathryn VonAldenbruck a chance to show they are thriving in the moment while raising money for the breakthroughs of…
Yukio Suzuki, MD, PhD, of Columbia University College of Physicians and Surgeons, discusses data showing that reproductive-age patients with early-stage endometrial cancer who use fertility-preserving…
Treatment with zanubrutinib (Brukinsa) was found to have cost savings and quality-adjusted life year benefits compared with acalabrutinib (Calquence) in patients with B-cell malignancies.
A preclinical study suggests the microbiome may be able to influence the severity of GVHD after bone marrow transplant through donor immune cells that recognize…
Alicia Morgans, MD, MPH, of Dana-Farber Cancer Institute, and Karim Fizazi, MD, PhD, of Institut Gustave Roussy and the University of Paris-Saclay, discuss a second…
Arsenic trioxide combined with all-trans retinoic acid and idarubicin significantly improved event-free survival vs ATRA and chemotherapy in patients with newly diagnosed, high-risk acute promyelocytic…